[{"uuid": "d8a1012a-a2d2-39d1-a9cc-faff307ab008", "title": "UBS Cuts Price Target on ALX Oncology Holdings to $2.20 From $4, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/ubs-cuts-price-target-alx-125933836.html", "providerPublishTime": 1737982773, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "c841ea08-e005-360f-9324-9b2a624bd4ba", "title": "ALX Oncology Shares Drop 15% Following Positive Phase 2", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/alx-oncology-shares-drop-15-194443574.html", "providerPublishTime": 1737661483, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/slb6hco9s4qvtSd.Xyb6oQ--~B/aD0zNjQ4O3c9NTQ3MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/ac90e83fbe2c24857411d69cfbec7675", "width": 5472, "height": 3648, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/i6H5JMJ4Poi33efxhBLGXg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ac90e83fbe2c24857411d69cfbec7675", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "7b46c776-0991-3cc3-b052-7182272a0213", "title": "ALX Oncology Names New CFO; Shares Rise", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/alx-oncology-names-cfo-shares-182401847.html", "providerPublishTime": 1737570241, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "80c25172-b0ba-3e5b-b9a9-f8ea1715ee62", "title": "ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in  Patients with HER2-Positive Gastric Cancer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-presents-positive-updated-130000083.html", "providerPublishTime": 1737637200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1F6udGkDHUGd2scXmK9GRA--~B/aD0xMDEwO3c9MTU1NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 1556, "height": 1010, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YFaNaL.7xdVD43tpzHv0QA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "bf803b09-73bb-3008-bb1c-327f99db4af5", "title": "ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-reports-inducement-grant-210100267.html", "providerPublishTime": 1737579660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1F6udGkDHUGd2scXmK9GRA--~B/aD0xMDEwO3c9MTU1NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 1556, "height": 1010, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YFaNaL.7xdVD43tpzHv0QA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "e472481c-700d-33b9-92b4-08d574d4c1ce", "title": "Sector Update: Health Care", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-203137908.html", "providerPublishTime": 1737577897, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "0ddbccf3-3837-3f1d-a66d-e708f705ea07", "title": "Sector Update: Health Care Stocks Softer Late Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-softer-205205529.html", "providerPublishTime": 1737579125, "type": "STORY", "relatedTickers": ["ABT", "CLSD"]}, {"uuid": "dbbf649d-4036-394b-89c8-2038c8765864", "title": "ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-announces-further-additions-130000485.html", "providerPublishTime": 1737550800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1F6udGkDHUGd2scXmK9GRA--~B/aD0xMDEwO3c9MTU1NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 1556, "height": 1010, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YFaNaL.7xdVD43tpzHv0QA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "6c3190dc-7895-3d2f-8dbc-08915d07a5d9", "title": "ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-host-virtual-company-220000880.html", "providerPublishTime": 1737496800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1F6udGkDHUGd2scXmK9GRA--~B/aD0xMDEwO3c9MTU1NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 1556, "height": 1010, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YFaNaL.7xdVD43tpzHv0QA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6d242fee25e02dd59dd0e8f0b1f88671", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "dd90fb09-627a-315f-8523-ac480b2b064a", "title": "Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/alx-oncology-holdings-alxo-outperforming-144010781.html", "providerPublishTime": 1736260810, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/aDH3K02ilxL.wIxqZgf1dw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "3b48dfc4-ba4d-3732-8498-7923aeaa9b03", "title": "ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-present-43rd-annual-130000088.html", "providerPublishTime": 1736254800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i_glYKoB.RbJGfWXum7iOg--~B/aD0xMTA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 300, "height": 110, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/G5BzZxyKnXPBoG5t_wYZVA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "d1534af7-62ee-35b9-a3b7-a64a5a05abdb", "title": "3 US Penny Stocks With Market Caps Under $100M To Watch", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/3-us-penny-stocks-market-200526191.html", "providerPublishTime": 1736366726, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gnGTQ_q9KCdl7Xvx_ppB0g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fe4d5d105492213ce106a92b49639d4", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ooX5AtoQCMx8g9kEgh.tsQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fe4d5d105492213ce106a92b49639d4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "80fe1db3-8cf7-3219-bc45-6497dee46cf2", "title": "Alx Oncology shares down in pre-market as Jefferies downgrades stock to 'hold'", "publisher": "Investing.com", "link": "https://finance.yahoo.com/news/alx-oncology-shares-down-pre-135740978.html", "providerPublishTime": 1734616660, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "8a7d0be3-6894-390e-95df-ff87f478d21a", "title": "Top Midday Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-midday-decliners-184807305.html", "providerPublishTime": 1734634087, "type": "STORY", "relatedTickers": ["ALXO", "LW", "MU"]}, {"uuid": "d5875d46-f1b0-34c4-809a-334e3a95be1e", "title": "ALX Oncology Shares Fall After Downgrade From Jefferies", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/alx-oncology-shares-fall-downgrade-183320083.html", "providerPublishTime": 1734633200, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "f231e059-939d-3f29-8aaf-bc286c4ebc4f", "title": "Jefferies Downgrades ALX Oncology to Hold From Buy, Cuts Price Target to $2 From $12", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/jefferies-downgrades-alx-oncology-hold-123745639.html", "providerPublishTime": 1734611865, "type": "STORY", "relatedTickers": ["ALXO"]}, {"uuid": "e53b21e6-72da-36d7-9859-8c003ec6dce8", "title": "ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/alx-oncology-holdings-alxo-loses-143507371.html", "providerPublishTime": 1732199707, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/64vRzkiY9LXGPrpW4r2GRQ--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248", "width": 900, "height": 467, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/K_VbSLl5PAgBcdM4TzmL5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "b5628d92-473e-382d-8e4b-cd826f852c06", "title": "ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-present-updated-results-130000020.html", "providerPublishTime": 1734526800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i_glYKoB.RbJGfWXum7iOg--~B/aD0xMTA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 300, "height": 110, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/G5BzZxyKnXPBoG5t_wYZVA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}, {"uuid": "7f1b23a7-9072-345b-a566-1a8b4c8949e3", "title": "Sector Update: Health Care Stocks Decline Late Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-205635436.html", "providerPublishTime": 1734641795, "type": "STORY", "relatedTickers": ["LLY"]}, {"uuid": "497b8a47-ee44-3d82-8c2e-83e03f187f8b", "title": "ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/alx-oncology-host-virtual-company-130000244.html", "providerPublishTime": 1734008400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i_glYKoB.RbJGfWXum7iOg--~B/aD0xMTA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 300, "height": 110, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/G5BzZxyKnXPBoG5t_wYZVA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/716a5799e5dcdfa2dac57b2481b7d02e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALXO"]}]